Acute Leukemia, Acute Lymphocytic Leukemia, Hematological Cancers, Leukemia, Multiple Myeloma, Psychological Distress
Conditions
Keywords
Aplastic Anemia, Lymphatic Diseases, Leukemia, Leukemia, Lymphoid, Immunoproliferative Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Anemia, Quality of Life, Lymphoproliferative Disorders, Lymphoma, Multiple Myeloma
Brief summary
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
Detailed description
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.
Interventions
BEHAVIORALWriting A (Experimental informative writing)
Experimental informative writing
BEHAVIORALWriting B (Experimental noninformative writing)
Experimental noninformative writing
BEHAVIORALWriting C (Control informative writing)
Control informative writing
BEHAVIORALWriting D (Control noninformative writing)
Control noninformative writing
Sponsors
American Cancer Society, Inc.
University of North Carolina, Chapel Hill
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed * Be at least 18 years old now (and at least 16 when they had their transplant) * Speak English * Have telephone service
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychological Adjustment | At screening, baseline and 3 months following intervention |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life | At screening, baseline and 3 months following intervention |
Countries
United States
Outcome results
None listed